SYRE financials
Spyre Therapeutics (SYRE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
SYRE income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | -$171.65M | -$209.56M | -$155.20M | -1.98 |
| 2024 | $0.00 | $0.00 | -$208.57M | -$208.02M | -3.18 |
| 2023 | $886.00K | $886.00K | -$242.30M | -$338.79M | -46.15 |
| 2022 | $2.33M | $2.33M | -$84.78M | -$83.81M | -24.86 |
| 2021 | $18.74M | $18.74M | -$65.65M | -$65.80M | -25.02 |
| 2020 | $0.00 | -$1.62M | -$81.48M | -$80.89M | -37.89 |